| Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (6), 920-928, 2019 | 709 | 2019 |
| Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer D Hammerl, JWM Martens, M Timmermans, M Smid, AM Trapman-Jansen, ... Nature communications 12 (1), 5668, 2021 | 108 | 2021 |
| DeepSMILE: Contrastive self-supervised pre-training benefits MSI and HRD classification directly from H&E whole-slide images in colorectal and breast cancer Y Schirris, E Gavves, I Nederlof, HM Horlings, J Teuwen Medical image analysis 79, 102464, 2022 | 68 | 2022 |
| Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer I Nederlof, D De Bortoli, Y Bareche, B Nguyen, M De Maaker, GKJ Hooijer, ... Breast cancer research 21, 1-13, 2019 | 42 | 2019 |
| Increased HLA-G expression in term placenta of women with a history of recurrent miscarriage despite their genetic predisposition to decreased HLA-G levels MHC Craenmehr, I Nederlof, M Cao, JJM Drabbels, MJ Spruyt-Gerritse, ... International journal of molecular sciences 20 (3), 625, 2019 | 30 | 2019 |
| Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials J Hudeček, L Voorwerk, M van Seijen, I Nederlof, M de Maaker, ... NPJ Breast Cancer 6 (1), 15, 2020 | 28 | 2020 |
| The seed to success: The role of seminal plasma in pregnancy I Nederlof, T Meuleman, MLP van der Hoorn, FHJ Claas, M Eikmans Journal of Reproductive Immunology 123, 24-28, 2017 | 28 | 2017 |
| DeepSMILE: self-supervised heterogeneity-aware multiple instance learning for DNA damage response defect classification directly from H&E whole-slide images Y Schirris, E Gavves, I Nederlof, HM Horlings, J Teuwen arXiv preprint arXiv:2107.09405, 2021 | 26 | 2021 |
| Risk factors for severe acute graft-versus-host disease in donor graft composition A Stikvoort, A Gaballa, M Solders, I Nederlof, B Önfelt, B Sundberg, ... Biology of Blood and Marrow Transplantation 24 (3), 467-477, 2018 | 22 | 2018 |
| A high-dimensional window into the micro-environment of triple negative breast cancer I Nederlof, HM Horlings, C Curtis, M Kok Cancers 13 (2), 316, 2021 | 20 | 2021 |
| LBA13 Nivolumab and ipilimumab in early-stage triple negative breast cancer (TNBC) with tumor-infiltrating lymphocytes (TILs): First results from the BELLINI trial I Nederlof, OI Isaeva, N Bakker, M de Graaf, RF Salgado, N Klioueva, ... Annals of Oncology 33, S1382, 2022 | 19 | 2022 |
| Interobserver agreement of PD-L1/SP142 immunohistochemistry and tumor-infiltrating lymphocytes (TILs) in distant metastases of triple-negative breast cancer: a proof-of-concept … MR Van Bockstal, M Cooks, I Nederlof, M Brinkhuis, A Dutman, ... Cancers 13 (19), 4910, 2021 | 14 | 2021 |
| Tipping the balance: inhibitory checkpoints in intestinal homeostasis ME Joosse, I Nederlof, LSK Walker, JN Samsom Mucosal Immunology 12 (1), 21-35, 2019 | 14 | 2019 |
| Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. L Voorwerk, M Slagter, HM Horlings, K Sikorska, KK van de Vijver, ... Nature medicine 25 (7), 1175-1175, 2019 | 12 | 2019 |
| Facts and hopes in immunotherapy for early-stage triple-negative breast cancer I Nederlof, L Voorwerk, M Kok Clinical Cancer Research 29 (13), 2362-2370, 2023 | 5 | 2023 |
| Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer I Nederlof, S Hajizadeh, F Sobhani, SEA Raza, K AbdulJabbar, R Harkes, ... NPJ Breast Cancer 8 (1), 56, 2022 | 4 | 2022 |
| Differential survival and therapy benefit of patients with breast cancer are characterized by distinct epithelial and immune cell microenvironments L Kester, D Seinstra, AGJ van Rossum, C Vennin, M Hoogstraat, ... Clinical Cancer Research 28 (5), 960-971, 2022 | 4 | 2022 |
| Recognizing a non-classical telomeropathy before hematopoietic stem cell transplantation in pediatric patients: a case series I Nederlof, CA Lindemans, MB Bierings, AB Mohseny, D Bresters, ... HemaSphere 3 (4), e282, 2019 | 3 | 2019 |
| 3O Spatial analysis of lymphocytes and fibroblasts identifies biological relevant patterns in estrogen receptor positive breast cancer I Nederlof, S Hajizadeh, F Sobhani, SA Raza, C Desmedt, RF Salgado, ... Annals of Oncology 32, S22-S23, 2021 | 1 | 2021 |
| The temporal influence of the tumor microenvironment in response to checkpoint blockade NF Greenwald, I Nederlof, H Horlings, M Kok, C Curtis, M Angelo Cancer Research 84 (6_Supplement), 3894-3894, 2024 | | 2024 |
